MyAverix Finance
NS · Healthcare
Starsource Multitrade Ltd (506365)
Pharmaceuticals & Biotechnology
Starsource Multitrade Ltd (506365) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $144.00M, P/E ratio is -1.25, net margin is -678.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 506365
Starsource Multitrade Ltd (506365) — FAQ
What is Starsource Multitrade Ltd's market cap?
Starsource Multitrade Ltd (506365) has a reported market cap of $144.00M (data as of 2026-07-10).
What is 506365's P/E ratio?
The price-to-earnings (P/E) ratio for Starsource Multitrade Ltd (506365) is -1.25 (data as of 2026-07-10).
Does Starsource Multitrade Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Starsource Multitrade Ltd (506365). Check the MyAverix Finance app for the latest dividend data.
What sector is Starsource Multitrade Ltd in?
Starsource Multitrade Ltd (506365) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 506365 listed on?
506365 is listed on NS.
What is Starsource Multitrade Ltd's net margin?
Starsource Multitrade Ltd (506365) reports a net margin of -678.8% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.